Natalya Davies
Stock Analyst at Rothschild & Co Redburn
(3.84)
# 1,920
Out of 5,022 analysts
10
Total ratings
90%
Success rate
30.5%
Average return
Main Sectors:
Stocks Rated by Natalya Davies
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MTD Mettler-Toledo International | Initiated Coverage: Sell | $1,200 | $1,486.19 | -19.26% | 1 | Sep 2, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Reiterated: Buy | €285.00 | €251.40 | +13.37% | 1 | Apr 17, 2026 | |
| MRK Merck & Co. | Reiterated: Buy | $179 | $144.30 | +24.05% | 1 | Apr 17, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $160 | $181.70 | -11.94% | 1 | Apr 17, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | $575 → $620 | $654.80 | -5.31% | 2 | Apr 17, 2026 | |
| BRKR Bruker | Reiterated: Buy | $60 | $63.24 | -5.12% | 2 | Nov 20, 2025 | |
| A Agilent Technologies | Initiated Coverage: Buy | $165 | $167.78 | -1.66% | 1 | Oct 8, 2025 | |
| WAT Waters | Initiated Coverage: Buy | $390 | $425.21 | -8.28% | 1 | Oct 8, 2025 |
Mettler-Toledo International
Sep 2, 2026
Initiated Coverage: Sell
Price Target: $1,200
Current: $1,486.19
Upside: -19.26%
Sartorius Aktiengesellschaft
Apr 17, 2026
Reiterated: Buy
Price Target: €285.00
Current: €251.40
Upside: +13.37%
Merck & Co.
Apr 17, 2026
Reiterated: Buy
Price Target: $179
Current: $144.30
Upside: +24.05%
Repligen
Apr 17, 2026
Initiated Coverage: Buy
Price Target: $160
Current: $181.70
Upside: -11.94%
Thermo Fisher Scientific
Apr 17, 2026
Reiterated: Buy
Price Target: $575 → $620
Current: $654.80
Upside: -5.31%
Bruker
Nov 20, 2025
Reiterated: Buy
Price Target: $60
Current: $63.24
Upside: -5.12%
Agilent Technologies
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $165
Current: $167.78
Upside: -1.66%
Waters
Oct 8, 2025
Initiated Coverage: Buy
Price Target: $390
Current: $425.21
Upside: -8.28%